ABIGO PHARMA A/S: Financial statements 2022
CVR: 12927983
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ABIGO PHARMA A/S (CVR 12927983) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 12,886,055 and a net result of DKK 165,903 compared with DKK 4,629,963 the year before. The profit margin was 1.3%. Equity in the 2022 report amounted to DKK 4,637,077. The solvency ratio was 71.9%. The company had 4 employees in the financial year.
- Revenue
- DKK 12,886,055
- Gross Profit
- DKK 3,472,221
- Profit/Loss
- DKK 165,903
- Equity
- DKK 4,637,077
- Total Assets
- DKK 6,449,746
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 12.9 mio. | 3.5 mio. | 166 t. | 4.6 mio. | 4 |
| 2021 | - | 12.9 mio. | 4.6 mio. | 4.5 mio. | 7 |
| 2020 | - | 6.2 mio. | 155 t. | -159 t. | 8 |
| 2019 | - | 5.8 mio. | -146 t. | -314 t. | 8 |
| 2018 | - | 5.7 mio. | -240 t. | -168 t. | 8 |
Official annual report
Keep an eye on ABIGO PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ABIGO PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 12,897,966, and the net result was DKK 4,629,963.
As of April 11, 2022, EY Godkendt Revisionspartnerselskab has been appointed auditor of ABIGO PHARMA A/S.
As of April 11, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABIGO PHARMA A/S.
About ABIGO PHARMA A/S
ABIGO PHARMA A/S was a Danish company of the type Aktieselskab based in Allerød, founded in 1989. The company has been dissolved on 27 June 2024. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company was previously named DHC A/S and DANSK HELSEMIDDEL CENTER A/S. The company has 1 employee (2023). In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. Equity in the 2023 report amounted to DKK 4,838,794.